Annual Retained Earnings
-$530.75 M
-$146.96 M-38.29%
31 December 2023
Summary:
Kymera Therapeutics annual retained earnings is currently -$530.75 million, with the most recent change of -$146.96 million (-38.29%) on 31 December 2023. During the last 3 years, it has fallen by -$401.99 million (-312.19%). KYMR annual retained earnings is now -1407.39% below its all-time high of -$35.21 million, reached on 31 December 2018.KYMR Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$683.86 M
-$62.49 M-10.06%
30 September 2024
Summary:
Kymera Therapeutics quarterly retained earnings is currently -$683.86 million, with the most recent change of -$62.49 million (-10.06%) on 30 September 2024. Over the past year, it has dropped by -$167.47 million (-32.43%). KYMR quarterly retained earnings is now -794.45% below its all-time high of -$76.46 million, reached on 31 December 2019.KYMR Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
KYMR Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -38.3% | -32.4% |
| 3 y3 years | -312.2% | -250.6% |
| 5 y5 years | -1407.4% | - |
KYMR Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -312.2% | at low | -250.6% | at low |
| 5 y | 5 years | -1407.4% | at low | -794.5% | at low |
| alltime | all time | -1407.4% | at low | -794.5% | at low |
Kymera Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$683.86 M(+10.1%) |
| June 2024 | - | -$621.37 M(+7.3%) |
| Mar 2024 | - | -$579.31 M(+9.1%) |
| Dec 2023 | -$530.75 M(+38.3%) | -$530.75 M(+2.8%) |
| Sept 2023 | - | -$516.38 M(+11.4%) |
| June 2023 | - | -$463.52 M(+9.1%) |
| Mar 2023 | - | -$424.72 M(+10.7%) |
| Dec 2022 | -$383.79 M | -$383.79 M(+10.0%) |
| Sept 2022 | - | -$348.93 M(+14.1%) |
| June 2022 | - | -$305.92 M(+15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -$265.67 M(+16.0%) |
| Dec 2021 | -$228.98 M(+77.8%) | -$228.98 M(+17.4%) |
| Sept 2021 | - | -$195.08 M(+17.2%) |
| June 2021 | - | -$166.50 M(+17.4%) |
| Mar 2021 | - | -$141.84 M(+10.2%) |
| Dec 2020 | -$128.76 M(+68.4%) | -$128.76 M(+10.9%) |
| Sept 2020 | - | -$116.08 M(+7.4%) |
| June 2020 | - | -$108.09 M(+41.4%) |
| Dec 2019 | -$76.46 M(+117.1%) | -$76.46 M |
| Dec 2018 | -$35.21 M | - |
FAQ
- What is Kymera Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Kymera Therapeutics?
- What is Kymera Therapeutics annual retained earnings year-on-year change?
- What is Kymera Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Kymera Therapeutics?
- What is Kymera Therapeutics quarterly retained earnings year-on-year change?
What is Kymera Therapeutics annual retained earnings?
The current annual retained earnings of KYMR is -$530.75 M
What is the all time high annual retained earnings for Kymera Therapeutics?
Kymera Therapeutics all-time high annual retained earnings is -$35.21 M
What is Kymera Therapeutics annual retained earnings year-on-year change?
Over the past year, KYMR annual retained earnings has changed by -$146.96 M (-38.29%)
What is Kymera Therapeutics quarterly retained earnings?
The current quarterly retained earnings of KYMR is -$683.86 M
What is the all time high quarterly retained earnings for Kymera Therapeutics?
Kymera Therapeutics all-time high quarterly retained earnings is -$76.46 M
What is Kymera Therapeutics quarterly retained earnings year-on-year change?
Over the past year, KYMR quarterly retained earnings has changed by -$167.47 M (-32.43%)